Effective Monday, 07/03/2023, the Office of Clinical Trial Activation (OCTA) is moving forward with a single PI approval of the coverage analysis and study budget. 

In effort to reduce duplicative reviews and approvals, PIs will no longer approve the coverage analysis before budget development begins. The study team and PI will review/approve the coverage analysis and budget in conjunction before budget negotiations. 

Please review our updated workflow. If you have any questions, please contact [email protected].